The aim of this study is to estimate the accuracy of CL Detect Rapid Test™ compared to a composite reference standard test (Direct examination of skin smears + PCR test) in patients with clinically suspected Cutaneous Leishmaniasis disease in Morocco.
Study participants are recruited in nine health centers located in fourthree CL endemic provinces. The RDT under evaluation (index test) is the CL Detect™ Rapid Test (InBios, USA); a membrane-based amastigote antigen (peroxidoxin) detection test. The reference standard consists of two tests: direct examination of skin smears and PCR. For each patient, the health professional takes one dental broach sample and four skin smear samples from a single lesion. The dental broach sample is used for the RDT, which is done once. The skin smear samples are sent to provincial laboratories for microscopy testing and to reference laboratories in Morocco and Belgium for PCR testing by ITS1 PCR, Hsp70 genotyping and parasite load determination. Readers of index and reference tests do not have access to clinical information or any other test results. The results of the test under evaluation (RDT) and the molecular tests (PCR) are not communicated to the patient or her/his physician, as case management has to follow current clinical guidelines.
Study Type
OBSERVATIONAL
Enrollment
219
Primary Health center
Arfoud, Errachidia, Morocco
Health primary center
Tinajdad, Errachidia, Morocco
Primary Health Center
Sekoura, Ouarzazates, Morocco
Primary Health Center
Tarmight, Ouarzazates, Morocco
Positive result for this test
Time frame: 50 minutes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Primary Health Center
Tazouta, Sefrou, Morocco
Primary Health Center
Boumalne Dades, Tinghir, Morocco
Primary Health Center
Kelaat Mgouna, Tinghir, Morocco
Primary Health Center
Sefrou, Morocco
Primary Health Center
Sidi Kacem, Morocco